Checkpoint inhibitors have revolutionized cancer treatment. However, only a minority of
patients respond to these immunotherapies. Here, we report that blocking the inhibitory NKG2A …

The human leukocyte antigen–A2 (HLA-A2)–restricted zinc transporter 8 186–194 (ZnT8
186–194 ) and other islet epitopes elicit interferon-γ secretion by CD8 + T cells preferentially in …

Although CD8 + T-cell-mediated autoimmune β cell destruction occurs in type 1 diabetes (T1D),
the target epitopes processed and presented by β cells are unknown. To identify them, …

Although the COVID‐19 pandemic peaked in March/April 2020 in France, the prevalence of
infection is barely known. Using high‐throughput methods, we assessed herein the …

Low levels of B-cell-receptor (BCR) expression are the hallmark of tumoral B lymphocytes in
B-cell chronic lymphocytic leukemia (B-CLL). These cells also respond inadequately to …

Some nonpathogenic bacteria were found to have protective effects in mouse models of
allergic and autoimmune diseases. These “probiotics” are thought to interact with dendritic cells …

TLR9 is expressed in cells of the innate immune system, as well as in B lymphocytes and their
progenitors. We investigated the effect of the TLR9 ligand CpG DNA on the proliferation of …

Activation-induced cytidine deaminase (AID) is key to initiating somatic hypermutation (SHM)
and class switch recombination (CSR), but its mode of action and regulation remains …

In type 1 diabetes, autoimmune β-cell destruction may be favored by neoantigens harboring
posttranslational modifications (PTMs) such as citrullination. We studied the recognition of …

Introduction The microbiota controls a variety of biological functions, including immunity,
and alterations of the microbiota in early life are associated with a higher risk of developing …